In a previous report, RA patients with LIP who complained of acute abdominal pain were treated with conventional synthetic disease-modifying antirheumatic drugs in 90% of cases, tumor necrosis factor-α inhibitors in 60% of cases, and tocilizumab in 27% of cases [9]. The gene discussed is TNF; the disease is rheumatoid arthritis.